SPACE PEPTIDES PHARMACEUTICAL

PEPTIDE DRUG DISCOVERY (CRO) AND MANUFACTURE (CDMO)

Space Peptides appoints Dr. Simon Nebel as Business advisor

Space Peptides Pharmaceutical is pleased to welcome Dr. Simon Nebel as Business Advisor.

Dr. Simon Nebel has participated in the financing of a number of life science companies and the M&A transactions for Aravis portfolio companies. Simon has been the board member or observer in fourteen companies. Before joining Aravis, he was a group strategist at UBS. Dr. Nebel got his PhD in Biophysics at the Biocentre of the University of Basel and an MBA from the London Business School.